Site(s) of infection in the spontaneous clearance and no spontaneous clearance groups
| Spontaneous clearance group (pretrial NAAT) | No spontaneous clearance group (enrolment NAAT) | |||||||
| Female (n=19) | Heterosexual men (n=10) | MSM (n=54) | Total (n=83) | Female (n=97) | Heterosexual men (n=24) | MSM (n=200) | Total (n=321*) | |
| Genital, n (%) | 13 (68.4) | 9 (90) | 1 (1.9) | 23 (27.7) | 11 (11.3) | 21 (87.5) | 1 (0.5) | 33 (10.3) |
| Rectal, n (%) | 2 (10.5) | 0 | 21 (38.9) | 23 (27.7) | 2 (2.1) | 0 | 63 (31.5) | 65 (20.2) |
| Pharyngeal, n (%) | 3 (15.8) | 1 (10.0) | 31 (57.4) | 35 (42.2) | 13 (13.4) | 1 (4.2) | 78 (39.0) | 92 (28.7) |
| Genital and rectal, n (%) | 0 | 0 | 0 | 0 | 45 (46.4) | 1 (4.2) | 5 (2.5) | 51 (15.9) |
| Genital and pharyngeal, n (%) | 0 | 0 | 0 | 0 | 4 (4.1) | 1 (4.2) | 5 (2.5) | 10 (3.1) |
| Pharyngeal and rectal, n (%) | 0 | 0 | 1 (1.9)* | 1 (1.2) | 1 (1.0) | 0 | 44 (22.0) | 45 (14.0) |
| Genital, rectal and pharyngeal, n (%) | 1 (5.3) | 0 | 0 | 1 (1.2) | 21 (21.6) | 0 | 4 (2.0) | 25 (7.8) |
One transperson not included due to small numbers.
*This patient cleared infection at the pharyngeal site but not the rectal site.
MSM, man who has sex with men; NAAT, Nucleic acid amplification test.